| juvenile dermatomyositis |
367 |
| panniculitis |
367 |
| pediatric |
367 |
| subcutaneous tissue |
367 |
| corticosteroid |
273 |
| intraarticular injection |
273 |
| knee osteoarthritis |
273, 335 |
| platelet rich plasma |
273 |
| collagen-induced arthritis |
309 |
| rheumatoid arthritis |
309, 328, 316, 251 |
| sorafenib |
309 |
| dermal fibrosis |
288 |
| paricalcitol |
288 |
| scleroderma |
288 |
| wnt/β-catenin pathway |
288 |
| children |
282 |
| concomitant |
282 |
| familial mediterranean fever |
282 |
| severity |
282 |
| balance disorder |
328 |
| foot deformity |
328 |
| functional status |
328 |
| exercise |
295 |
| physical function |
295 |
| physical therapy |
295 |
| osteoarthritis |
295 |
| clinically amyopathic dermatomyositis |
376 |
| dermatomyositis |
376 |
| diffuse alveolar damage |
376 |
| organizing pneumonia |
376 |
| polymyositis |
376 |
| interstitial lung diseases |
322 |
| pulmonary hypertension |
322 |
| systemic sclerosis |
322, 316 |
| methotrexate |
302 |
| mizoribine |
302 |
| polymyalgia rheumatica |
302 |
| prednisone |
302 |
| fatigue |
316 |
| quality of life |
316 |
| isokinetic muscle performance |
335 |
| kinesiology taping |
335 |
| western ontario and mcmaster osteoarthritis index |
335 |
| intestinal perforation |
372 |
| pneumatosis intestinalis |
372 |
| tocilizumab |
372 |
| juvenile localized scleroderma |
344 |
| juvenile systemic sclerosis |
344 |
| raynaud’s phenomenon |
344 |
| skin stiffening |
344 |
| behçet’s disease |
352 |
| hla-b*51 |
352 |
| mica |
352 |
| mica*006 |
352 |
| mica*009 |
352 |
| disease modifying anti-rheumatic drugs |
251 |
| management |
251 |
| treatment recommendations |
251 |
| turkish league against rheumatism |
251 |
| discoid lupus |
358 |
| systemic lupus erythematosus |
358 |
| transforming growth factor-beta 1 |
358 |
